England - April to June 2015 a
- 89,589 people set a quit date through NHS Stop Smoking Services and at the 4 week follow-up 44,742 people (50 per cent) had successfully quit (self-reported)b.
- 72 per cent of successful quitters (self-reported)b had their results confirmed by Carbon Monoxide (CO) verificationc.
- Of those setting a quit date, success increased with age, from 42 per cent of those aged under 18, to 57 per cent of those aged 60 and over.
- Of the 4,234 pregnant women who set a quit date, 1,917 successfully quit (self-reported)b (45 per cent). Of these 63 per cent had their results confirmed by CO verificationc.
- Among the nine regions, Yorkshire and the Humber reported the highest proportion of successful quitters (self-reported)b (57 per cent), whilst the North East reported the lowest success rate (44 per cent)d.
- Of the 149 Local Authorities (LAs) who submitted data, Warrington Borough Council reported the highest proportion of successful quitters (self-reported)b (82 per cent) followed by Borough of Poole Councile (81 per cent). In contrast, London Borough of Lambeth Council reported the lowest success rate (23 per cent) with London Borough of Southwark Council being the next lowest (24 per cent)d.
Treatment and Expenditure
- 'One-to-one support' (73,077) was the most widely used Intervention Typef and had a success rate of 49 per cent. Whilst, 'Telephone support' was used by far fewer quitters (2,414) but had the highest success rate at 56 per centd.
- 'General practice' was the most common Intervention Settingf with 33,938 people setting a quit date and 15,805 (47 per cent) successfully quitting. A 'Hospital' setting was used by 2,754 people setting a quit date but had the highest success rate, (59 per cent) with 1,613 people successfully quittingd. Those classed as 'Other' had a similar success rate (59 per cent) with 3,326 setting a quit date and 1,954 successfully quitting.
- The most common pharmacotherapy received by those setting a quit date was a combination of licensed NCPs concurrently (33 per cent). This compares to 26 per cent who receive a single Nicotine Containing Product (NCP) and 27 per cent who used Varenicline (Champix) only. Six per cent of people setting a quit date did not receive any pharmacotherapy, and the remaining 8 per cent received another type of pharmacotherapy or the type they received was not known.
- There were differences in the proportion successfully quitting by the type of pharmacotherapy receivedf. 68 per cent of those who used a 'licensed medication and an unlicensed NCP consecutively' successfully quit. This compares to those who received 'licensed NCP and/ or Bupropion (Zyban) and/ or Varenicline (Champix) consecutively' or received 'combination of licensed NCPs concurrently' (46 per cent respectively).
- 58 per cent of people setting a quit date (51,922) were eligible to receive free prescriptions and 57 per cent of successful quitters (25,332) were eligible. This gave a success rate of 49 per cent for those eligible to receive free prescriptions.
- Not all local authorities returned all data items. No estimates have been made for missing data so national and regional totals presented here will be an underestimate. See data quality statement for more information.
- A client is counted as a 'self-reported 4-week quitter' if when assessed 4 weeks after the designated quit date, they declare that they have not smoked, even a single puff on a cigarette, in the past two weeks.
- Carbon Monoxide (CO) validation measures the level of carbon monoxide in the bloodstream and provides an indication of the level of use of tobacco: it is a motivational tool for clients as well as validation of their smoking status. CO validation should be attempted on all clients who self-report as having successfully quit at the 4-week follow-up, except those who were followed up by telephone.
- Note that these are not standardised rates.
- Borough of Poole Council has reported a reduced number of those setting a quite date due to the commissioning of a new service.
- These data should not be used to assess or compare the clinical effectiveness of the various pharmacotherapies or intervention types and settings as they reflect only the results obtained through the NHS Stop Smoking Services, and are not based on clinical trials. For example, a particular intervention type may be used more often for heavy smokers which will reduce the quit rate. A trained stop smoking advisor discusses and agrees the treatment option with each client.